Common Contracts
65 similar null contracts by Cumberland Pharmaceuticals Inc
March 9, 2023 John Hamm Brentwood, TN 37216Cumberland Pharmaceuticals Inc • March 15th, 2023 • Pharmaceutical preparations
Effective January 1, 2023, this letter agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”) In consideration of your appointment as Chief Financial Officer the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
March 9, 2023 Chris Bitterman Alpharetta, GA 37090Cumberland Pharmaceuticals Inc • March 15th, 2023 • Pharmaceutical preparations
Effective January 1, 2023, this letter agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”) In consideration of your appointment as Vice President of Sales and Marketing the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
March 9, 2023 Todd Anthony Franklin, TN 37064Cumberland Pharmaceuticals Inc • March 15th, 2023 • Pharmaceutical preparations
Effective January 1, 2023, this letter agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”) In consideration of your appointment as Vice President of Organizational Development the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
March 9, 2023Cumberland Pharmaceuticals Inc • March 15th, 2023 • Pharmaceutical preparations
Effective January 1, 2023, this letter agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”) In consideration of your appointment as Chief Executive Officer of the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
March 9, 2023 James “Jim” Herman Nashville, TN 37221Cumberland Pharmaceuticals Inc • March 15th, 2023 • Pharmaceutical preparations
Re: Employment of Jim Herman Executive Vice President National Accounts & Chief Compliance Officer as by Cumberland Pharmaceuticals Inc.
March 7, 2022Cumberland Pharmaceuticals Inc • March 13th, 2023 • Pharmaceutical preparations
Re: Employment of John Hamm as Senior Director of Finance & Accounting & Chief Financial Officer Cumberland Pharmaceuticals Inc.
March 7, 2022Cumberland Pharmaceuticals Inc • March 13th, 2023 • Pharmaceutical preparations
Re: Employment of James Herman as Executive Vice President, National Accounts and Chief Compliance Officer Cumberland Pharmaceuticals Inc.
March 7, 2022Cumberland Pharmaceuticals Inc • March 13th, 2023 • Pharmaceutical preparations
Effective January 1, 2022, this letter agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”) In consideration of your appointment as Chief Executive Officer of the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
March 7, 2022Cumberland Pharmaceuticals Inc • May 13th, 2022 • Pharmaceutical preparations
Re: Employment of John Hamm as Senior Director of Finance & Accounting & Chief Financial Officer Cumberland Pharmaceuticals Inc.
March 7, 2022Cumberland Pharmaceuticals Inc • May 13th, 2022 • Pharmaceutical preparations
Re: Employment of James Herman as Executive Vice President, National Accounts and Chief Compliance Officer Cumberland Pharmaceuticals Inc.
March 7, 2022Cumberland Pharmaceuticals Inc • May 13th, 2022 • Pharmaceutical preparations
Effective January 1, 2022, this letter agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”) In consideration of your appointment as Chief Executive Officer of the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
March 7, 2022Cumberland Pharmaceuticals Inc • May 13th, 2022 • Pharmaceutical preparations
Re: Employment of Leo Pavliv as Executive Vice President, Chief Development & Operations Officer by Cumberland Pharmaceuticals Inc.
May 14, 2021Cumberland Pharmaceuticals Inc • May 14th, 2021 • Pharmaceutical preparations
Re: Employment of John Hamm as Senior Director Finance & Accounting and Chief Financial Officer by Cumberland Pharmaceuticals Inc.
March 8, 2021Cumberland Pharmaceuticals Inc • March 12th, 2021 • Pharmaceutical preparations
Re: Employment of James L. Herman as Senior Vice President, National Accounts and Chief Compliance Officer by Cumberland Pharmaceuticals Inc.
March 8, 2021Cumberland Pharmaceuticals Inc • March 12th, 2021 • Pharmaceutical preparations • Tennessee
Effective January 1, 2021, this letter agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”) In consideration of your appointment as Chief Executive Officer of the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
March 8, 2021Cumberland Pharmaceuticals Inc • March 12th, 2021 • Pharmaceutical preparations
Re: Employment of Leo Pavliv as Executive Vice President, Operations and Chief Development Officer by Cumberland Pharmaceuticals Inc.
March 8, 2021Cumberland Pharmaceuticals Inc • March 12th, 2021 • Pharmaceutical preparations
Re: Employment of Martin E. Cearnal as Executive Vice President, Chief Commercial Officer by Cumberland Pharmaceuticals Inc.
March 8, 2021Cumberland Pharmaceuticals Inc • March 12th, 2021 • Pharmaceutical preparations
Re: Employment of Michael Bonner as Senior Director, Finance & Accounting; Chief Financial Officer by Cumberland Pharmaceuticals Inc.
March 16, 2020Cumberland Pharmaceuticals Inc • March 20th, 2020 • Pharmaceutical preparations
Re: Employment of Martin E. Cearnal as Executive Vice President, Chief Commercial Officer by Cumberland Pharmaceuticals Inc.
March 16, 2020Cumberland Pharmaceuticals Inc • March 20th, 2020 • Pharmaceutical preparations
Re: Employment of Michael Bonner as Senior Director, Finance & Accounting; Chief Financial Officer by Cumberland Pharmaceuticals Inc.
March 16, 2020Cumberland Pharmaceuticals Inc • March 20th, 2020 • Pharmaceutical preparations
Re: Employment of Leo Pavliv as Executive Vice President, Operations and Chief Development Officer by Cumberland Pharmaceuticals Inc.
March 16, 2020Cumberland Pharmaceuticals Inc • March 20th, 2020 • Pharmaceutical preparations • Tennessee
Effective January 1, 2020, this letter agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”) In consideration of your appointment as Chief Executive Officer of the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
March 16, 2020Cumberland Pharmaceuticals Inc • March 20th, 2020 • Pharmaceutical preparations
Re: Employment of James L. Herman as Senior Vice President, National Accounts and Chief Compliance Officer by Cumberland Pharmaceuticals Inc.
March 8, 2019Cumberland Pharmaceuticals Inc • March 12th, 2019 • Pharmaceutical preparations
Re: Employment of James L. Herman as Senior Vice President, National Accounts and Chief Compliance Officer by Cumberland Pharmaceuticals Inc.
March 8, 2019Cumberland Pharmaceuticals Inc • March 12th, 2019 • Pharmaceutical preparations
Re: Employment of Martin E. Cearnal as Executive Vice President, Chief Commercial Officer by Cumberland Pharmaceuticals Inc.
March 8, 2019Cumberland Pharmaceuticals Inc • March 12th, 2019 • Pharmaceutical preparations
Re: Employment of Leo Pavliv as Executive Vice President, Operations and Chief Development Officer by Cumberland Pharmaceuticals Inc.
March 8, 2019Cumberland Pharmaceuticals Inc • March 12th, 2019 • Pharmaceutical preparations • Tennessee
Effective January 1, 2019, this letter agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”) In consideration of your appointment as Chief Executive Officer of the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
March 8, 2019Cumberland Pharmaceuticals Inc • March 12th, 2019 • Pharmaceutical preparations
Re: Employment of Michael Bonner as Senior Director, Finance & Accounting; Chief Financial Officer by Cumberland Pharmaceuticals Inc.
March 9, 2018Cumberland Pharmaceuticals Inc • March 9th, 2018 • Pharmaceutical preparations
Re: Employment of Leo Pavliv as Executive Vice President, Operations and Chief Development Officer by Cumberland Pharmaceuticals Inc.
March 9, 2018Cumberland Pharmaceuticals Inc • March 9th, 2018 • Pharmaceutical preparations
Re: Employment of Michael Bonner as Senior Director, Finance & Accounting; Chief Financial Officer by Cumberland Pharmaceuticals Inc.
March 9, 2018Cumberland Pharmaceuticals Inc • March 9th, 2018 • Pharmaceutical preparations
Re: Employment of James L. Herman as Senior Vice President, National Accounts and Chief Compliance Officer by Cumberland Pharmaceuticals Inc.
March 9, 2018Cumberland Pharmaceuticals Inc • March 9th, 2018 • Pharmaceutical preparations • Tennessee
Effective January 1, 2018, this letter agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”) In consideration of your appointment as Chief Executive Officer of the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
March 9, 2018Cumberland Pharmaceuticals Inc • March 9th, 2018 • Pharmaceutical preparations
Re: Employment of Martin E. Cearnal as Executive Vice President, Chief Commercial Officer by Cumberland Pharmaceuticals Inc.
March 8, 2017Cumberland Pharmaceuticals Inc • March 13th, 2017 • Pharmaceutical preparations • Tennessee
Re: Employment of Martin E. Cearnal as Executive Vice President, Chief Commercial Officer by Cumberland Pharmaceuticals Inc.
March 8, 2017Cumberland Pharmaceuticals Inc • March 13th, 2017 • Pharmaceutical preparations
Re: Employment of James L. Herman as Senior Vice President, National Accounts and Chief Compliance Officer by Cumberland Pharmaceuticals Inc.
